严重无症状新发颈动脉狭窄行颈动脉内膜切除术后长期死亡风险的预测(PREMY2SE-CEA):一种新型风险评分的推导与验证
本研究回顾性收集2008至2016年两家意大利大学医院因严重(NASCET标准>70%)无症状颈动脉狭窄行择期颈动脉内膜切除术的连续患者数据,推导并内部验证(3:1随机抽样)5年死亡风险评分。1214例中推导队列901例、验证队列313例,含8个危险因素的评分对长期死亡预测良好:推导队列OR 1.38(95%CI 1.28-1.41,P<.001),验证队列OR 1.29(95%CI 1.21-1.37,P<.001),C=0.775(95%CI 0.74-0.80),验证队列预测与实际死亡率强相关(r=0.71,P<.001)。
要点
- 8个危险因素构成的PREMY2SE-CEA评分可预测无症状颈动脉狭窄行CEA后的5年死亡。
- 推导队列OR 1.38(95%CI 1.28-1.41,P<.001),验证队列OR 1.29(95%CI 1.21-1.37,P<.001)。
- 作者认为医生可用该评分辅助估计预期寿命,并选择性考虑预防性CEA。
核心结论
- 作者描述了用于无症状患者CEA后长期死亡的风险预测模型PREMY2SE-CEA的建立、评价与验证。
- 作者认为医生可用PREMY2SE-CEA评分工具补充对预期寿命的估计,并促使选择性考虑预防性CEA以改善干预的长期获益。
研究设计与样本
- 回顾性从专用数据库收集2008年至2016年两家意大利大学医院因严重(NASCET标准>70%)无症状颈动脉狭窄行择期CEA的连续患者。
- 共1214例患者,推导队列901例、验证队列313例,内部验证采用3:1随机抽样。
- 主要终点为5年死亡率,采用向后消除法的多因素logistic回归推导简约模型。
主要发现
- 含8个危险因素的风险评分对长期死亡预测良好:推导队列OR 1.38(95%CI 1.28-1.41,P<.001),验证队列OR 1.29(95%CI 1.21-1.37,P<.001)。
- 受试者工作特征曲线分析的区分度为C=0.775(95%CI 0.74-0.80),自助抽样样本中乐观校正曲线下面积为0.761(P<.001)。
- 验证队列中预测死亡率与实际死亡率强相关(r=0.71,P<.001)。
临床怎么用
- 作者认为医生可用PREMY2SE-CEA评分工具补充对预期寿命的估计,并促使选择性考虑预防性CEA以改善干预的长期获益。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the present study was to develop and validate a risk prediction model for the prediction of long-term mortality for patients with severe asymptomatic de novo carotid stenosis undergoing carotid endarterectomy (PREMY2SE-CEA). METHODS: Data were collected retrospectively from a dedicated database of consecutive patients who had undergone elective CEA for severe (>70% using the NASCET [North American Symptomatic Carotid Endarterectomy Trial] criteria) asymptomatic carotid stenosis at two Italian University Hospitals from 2008 through 2016. Internal validation of the score was performed after random sampling in a 3:1 fashion. The primary end point of the PREMY2SE-CEA risk score was the 5-year mortality. RESULTS: Of the 1214 patients, 901 were included in the derivation cohort and 313 in the validation cohort. Using multivariable logistic regression with backward elimination, a parsimonious model was derived. A risk score incorporating eight risk factors was generated and found to be highly predictive of long-term mortality in the derivation (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.28-1.41; P < .001) and validation (OR, 1.29; 95% CI, 1.21-1.37; P <.001) cohorts. The discrimination power in the receiver operating characteristic curve analysis was C = 0.775 (95% CI, 0.74-.80), and the optimism-corrected area under the curve in the bootstrapped samples was 0.761 (P < .001). A strong correlation was found between the predicted and actual mortality rates in the validation cohort (r = 0.71; P < .001). CONCLUSIONS: In the present study, we have described the development, evaluation, and validation of a risk prediction model (PREMY2SE-CEA) for long-term mortality after CEA in asymptomatic patients. Physicians could use the PREMY2SE-CEA risk scoring tool to complement their estimates of life expectancy and prompt selective consideration of prophylactic CEA to improve the long-term benefits of interventions.
引用
- Mastrorilli D, D'Oria M, Lepidi S, et al. Prediction of long-term mortality for patients with severe asymptomatic de novo carotid stenosis undergoing carotid endarterectomy (PREMY2SE-CEA): Derivation and validation of a novel risk score. J Vasc Surg. 2022. PMID: 36265668. doi:10.1016/j.jvs.2022.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。